SCHEMBL8020587

SCHEMBL8020587

O=C(O)C=Cc1cccc(OCc2cccnc2)c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.74
KDM4E B2RXH2 2/20 0.74
PKM P14618 1/20 0.74
SMN1; SMN2 Q16637 2/20 0.71
LMNA P02545 2/20 0.71
THRB P10828 2/20 0.71
TBXAS1 P24557 2/20 0.56
CYP4F2 P78329 1/20 0.55
CYP4A11 Q02928 1/20 0.55
GPR132 Q9UNW8 9/20 0.53
CCNB2 O95067 1/20 0.51
CDK1 P06493 1/20 0.51
CDK4 P11802 1/20 0.51
CCNB1 P14635 1/20 0.51
CCND1 P24385 1/20 0.51
CCNB3 Q8WWL7 1/20 0.51
PIM2 Q9P1W9 1/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8020581 1.00 ALDH1A1 (0.74) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL9434664 0.86 ALDH1A1 (0.72) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL8010387 0.86 TBXAS1 (0.67) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL8010384 0.86 TBXAS1 (0.67) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL2136926 0.86 ALDH1A1 (1.00) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL2136928 0.86 ALDH1A1 (1.00) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL9035635 0.82 MAOA (0.68) ALDH1A1SMN1; SMN2LMNATHRBGPR132
SCHEMBL9367470 0.79 ALDH1A1 (0.82) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL9367465 0.79 ALDH1A1 (0.82) ALDH1A1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL28011530 0.78 MAPK1 (0.64) LMNAGPR132CMKLR2CMKLR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6040309-A ACTIVE MATERIAL TREATING OF RESTENOSIS, RENAL FAILURE, PULMONARY HYPERTENSION, BENIGN PROSTATIC HYPERTROPHY, MALE ERECTILE DYSFUNCTION, CONGESTIVE HEART FAILURE, STROKE, ANGINA, ATHEROSCLEROSIS, CEREBRAL AND CARDIAC ISCHAEMIA PFIZER, INC. (US) 2000-03-21 US disclosed
EP-0921124-A1 Benzothiophene derivatives useful in therapy Pfizer Limited (GB) 1999-06-09 EP disclosed